CiteULike: guhjy's Morgan:TR [9 articles]

Predicting Clinical and Histological Outcomes Based on Standard Laboratory Tests In Advanced Chronic Hepatitis C.

Gastroenterology (17 September 2009)

by Marc G. Ghany, Anna S. Lok, James E. Everhart, et al.Gregory T. Everson, William M. Lee, Teresa M. Curto, Elizabeth C. Wright, Anne M. Stoddard, Richard K. Sterling, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Chihiro Morishima, Timothy R. Morgan, Jules L. Dienstag, HALT-C Trial Group

posted to halt-c by guhjy on 2009-10-29 02:32:02 as

Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma.

Gastroenterology (20 October 2009)

by Anna S. Lok, Richard K. Sterling, James E. Everhart, et al.Elizabeth C. Wright, John C. Hoefs, Adrian M. Di Bisceglie, Timothy R. Morgan, Hae-Young Y. Kim, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, HALT-C Trial Group

posted to hcc halt-c afp by guhjy on 2009-10-29 02:31:55 as

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial.

Hepatology (Baltimore, Md.) (5 August 2009)

by Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, et al.Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Jules L. Dienstag, Chihiro Morishima, HALT‐C Trial Group

posted to hcv halt-c by guhjy on 2009-10-29 02:23:57 as

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Hepatology (Baltimore, Md.), Vol. 49, No. 6. (June 2009), pp. 1847-1858.

posted to halt-c by guhjy on 2009-10-29 02:19:12 as

Gastroenterology, Vol. 137, No. 2. (August 2009), pp. 549-557.

by James E. Everhart, Anna S. Lok, Hae-Young Y. Kim, et al.Timothy R. Morgan, Karen L. Lindsay, Raymond T. Chung, Herbert L. Bonkovsky, Marc G. Ghany, HALT-C Trial Group

posted to obesity nash hcv halt-c bw by guhjy on 2009-10-29 02:13:54 as

Alcoholic hepatitis.

The New England journal of medicine, Vol. 360, No. 26. (25 June 2009), pp. 2758-2769.

by Michael R. Lucey, Philippe Mathurin, Timothy R. Morgan

posted to liver alcohol by guhjy on 2009-08-22 10:16:44 as

along with 1 person dmcclusky

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.

Alimentary pharmacology & therapeutics, Vol. 29, No. 5. (1 March 2009), pp. 589-601.

by G. T. Everson, M. L. Shiffman, J. C. Hoefs, et al.T. R. Morgan, R. K. Sterling, D. A. Wagner, J. L. Desanto, T. M. Curto, E. C. Wright, HALT-C Trial Group

posted to halt-c hcv rct by guhjy on 2008-12-19 03:43:04 as

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

The New England journal of medicine, Vol. 359, No. 23. (4 December 2008), pp. 2429-2441.

by Adrian M. Di Bisceglie, Mitchell L. Shiffman, Gregory T. Everson, et al.Karen L. Lindsay, James E. Everhart, Elizabeth C. Wright, William M. Lee, Anna S. Lok, Herbert L. Bonkovsky, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Kristin K. Snow, Jules L. Dienstag, HALT-C Trial Investigators

posted to halt-c hcv ifn rct by guhjy on 2008-12-16 11:36:58 as

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders

Controlled Clinical Trials, Vol. 25, No. 5. (October 2004), pp. 472-492.

by William M. Lee, Jules L. Dienstag, Karen L. Lindsay, et al.Anna S. Lok, Herbert L. Bonkovsky, Mitchell L. Shiffman, Gregory T. Everson, Adrian M. Di Bisceglie, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Elizabeth C. Wright, James E. Everhart

posted to hcv liver rct by guhjy on 2008-06-14 02:09:16 as

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

	Predicting Clinical and Histological Outcomes Based on Standard Laboratory Tests In Advanced Chronic Hepatitis C. [My Copy] Gastroenterology (17 September 2009) by Marc G. Ghany, Anna S. Lok, James E. Everhart, et al.Gregory T. Everson, William M. Lee, Teresa M. Curto, Elizabeth C. Wright, Anne M. Stoddard, Richard K. Sterling, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Chihiro Morishima, Timothy R. Morgan, Jules L. Dienstag, HALT-C Trial Group posted to halt-c by guhjy on 2009-10-29 02:32:02 as
	Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma. [My Copy] Gastroenterology (20 October 2009) by Anna S. Lok, Richard K. Sterling, James E. Everhart, et al.Elizabeth C. Wright, John C. Hoefs, Adrian M. Di Bisceglie, Timothy R. Morgan, Hae-Young Y. Kim, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, HALT-C Trial Group posted to hcc halt-c afp by guhjy on 2009-10-29 02:31:55 as
	Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial. [My Copy] Hepatology (Baltimore, Md.) (5 August 2009) by Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, et al.Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Jules L. Dienstag, Chihiro Morishima, HALT‐C Trial Group posted to hcv halt-c by guhjy on 2009-10-29 02:23:57 as
	Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. [My Copy] Hepatology (Baltimore, Md.), Vol. 49, No. 6. (June 2009), pp. 1847-1858. by Tania Mara M. Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, et al.Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O'Brien, HALT-C Trial Group posted to halt-c by guhjy on 2009-10-29 02:19:12 as
	Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. [My Copy] Gastroenterology, Vol. 137, No. 2. (August 2009), pp. 549-557. by James E. Everhart, Anna S. Lok, Hae-Young Y. Kim, et al.Timothy R. Morgan, Karen L. Lindsay, Raymond T. Chung, Herbert L. Bonkovsky, Marc G. Ghany, HALT-C Trial Group posted to obesity nash hcv halt-c bw by guhjy on 2009-10-29 02:13:54 as
	Alcoholic hepatitis. [My Copy] The New England journal of medicine, Vol. 360, No. 26. (25 June 2009), pp. 2758-2769. by Michael R. Lucey, Philippe Mathurin, Timothy R. Morgan posted to liver alcohol by guhjy on 2009-08-22 10:16:44 as along with 1 person dmcclusky
	Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial. [My Copy] Alimentary pharmacology & therapeutics, Vol. 29, No. 5. (1 March 2009), pp. 589-601. by G. T. Everson, M. L. Shiffman, J. C. Hoefs, et al.T. R. Morgan, R. K. Sterling, D. A. Wagner, J. L. Desanto, T. M. Curto, E. C. Wright, HALT-C Trial Group posted to halt-c hcv rct by guhjy on 2008-12-19 03:43:04 as
	Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. [My Copy] The New England journal of medicine, Vol. 359, No. 23. (4 December 2008), pp. 2429-2441. by Adrian M. Di Bisceglie, Mitchell L. Shiffman, Gregory T. Everson, et al.Karen L. Lindsay, James E. Everhart, Elizabeth C. Wright, William M. Lee, Anna S. Lok, Herbert L. Bonkovsky, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Kristin K. Snow, Jules L. Dienstag, HALT-C Trial Investigators posted to halt-c hcv ifn rct by guhjy on 2008-12-16 11:36:58 as
	Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders [My Copy] Controlled Clinical Trials, Vol. 25, No. 5. (October 2004), pp. 472-492. by William M. Lee, Jules L. Dienstag, Karen L. Lindsay, et al.Anna S. Lok, Herbert L. Bonkovsky, Mitchell L. Shiffman, Gregory T. Everson, Adrian M. Di Bisceglie, Timothy R. Morgan, Marc G. Ghany, Chihiro Morishima, Elizabeth C. Wright, James E. Everhart posted to hcv liver rct by guhjy on 2008-06-14 02:09:16 as

guhjy's Morgan:TR [9 articles] Export Sort

guhjy's tags

ckd	1738
rct	1204
dn	1146
cancer	1047
dm	1047
ma	979
cv	926
hd	859
tgfb	842
snp	772
ros	663
bp	644
meta-analysis	516
kidney	507
uae	501
mouse	494
stats	480
software	463
mirna	450
pt	449
genetics	449
proteomics	412
mortality	408
rat	390
fbl	379
tw	373
inflammation	371
proteinuria	356
pcr	353
mtor	352
akt	348
1	344
mc	343
db	337
acei	334
gdl	331
irs	327
test	325
inhibitor	324
method	323
urine	320
arb	316
apoptosis	314
aging	311
age	311
ms	310
hcv	304
aii	299
r	294
biomarker	287
hg	285
ppi	282
pi3k	278
bias	277
bayes	275
gwa	270
aki	269
s6k	266
emt	260
nutrition	255
rnai	249
egfr	249
p53	243
ub	242
fibrosis	236
obesity	236
erk	232
smad	229
cox	229
drug	225
pbmc	223
hcc	216
metab	214
hypoxia	212
gn	210
nfkb	205
herb	204
stz	196
collagen	192
albumin	189
lc	187
hif	184
longitudinal	179
pubmed	179
lmm	178
pkc	175
p38	174
gfr	174
ua	170
epigenetics	169
bioinf	166
japan	165
cea	163
power	163
gender	162
rage	162
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
stata	147
ctgf	147
book	146
network	146
liver	146
company	144
screening	137
rt	136
diet	136
phosphorylation	135
mt	134
seq	133
kinase	128
go	128
no	128
pathway	127
protein	127
cell-cycle	126
esrd	124
systems-biology	124
insulin	123
lipid	119
statin	117
creatinine	117
proliferation	113
mapk	109
senescence	109
podocyte	106
stat	106
tnf	104
fish	104
regression	103
pd	102
cad	102
case-control	102
gfr-formula	102
imputation	101
hypertrophy	101
imaging	100
nox	100
multiplicity	100
pparg	98
observational	98
rx	98
p21	98
sirt	97
methylation	96
cloning	96
pediatric	96
plasmid	96
at1	95
recurrent	94
blood	93
betel	93
src	91
ko	91
chf	91
nhanes	90
website	89
anemia	88
immunity	88
phenotype	88
diagnosis	87
toxicology	86
lr	86
review	86
uti	85
cytokine	84
epo	84
ebm	84
gene-therapy	84
china	83
environment	82
ampk	82
ca	81
cachexia	81
p	81
oat	81
nonp	81
hapmap	80
primer	78
autophagy	78
gout	78
qms	77
signaling	75
egf	75
eif	73
ace	73
missing	73
promoter	73
cox2	73
gpcr	72
surrogate	72
stone	72
gene-list	72
eqtl	72
lpd	72
p-value	71
col4	71
mv	71
4ebp	71
salt	70
foxo	69
jnk	69
phd	69
mgo	68
glycemia	67
uncertainty	66
pe	65
hts	65
uuo	65
chinese	65
tin	65
normalization	65
mirna-target	65
ifn	64
shc	64
association	64
hsp	63
enddysf	63
pla2	63
2dge	63
causation	63
acid-base	63
yeast	63
nrk49f	62
me	62
llcpk1	62
simulation	62
translation	62
smoking	62
pdgf	61
avf	61
confounding	61
ptm	61
oglcnac	61
change	60
infection	60
sas	60
melamine	60
mmp	60
outcome	60
cost	59
oral	59
pai1	59
crp	59
alcohol	58
hk2	58
vegf	57
rho	57
pls	57
urate-transporter	57
robust	57
achr	57
fluorescence	57
model-selection	57
semantic	56
rapamycin	56
calibration	56
aceiarb	56
ace2	55
ratio	55
competing-risk	55
ncrna	55
goldstd	55
cyclin-d1	54
ckd-progression	54
stem-cell	54
bone	54
workflow	54
estrogen	54
function	54
iron	54
std	53
dipstick	53
hsc	53
renoprotection	53
pld	53
k	53
histone	52
tf	52
qc	52
atm	52
dimerization	52
il6	52
fgf	52
hdac	51
lod	51
normoalbuminuria	51
pth	51
ab	51
epidemiology	51
matlab	50
adpkd	50
metformin	50
hepatocyte	50
wnt	50
arsenic	50
risk-ratio	50
reasoning	50
p27	50
mercury	50
graph	50
epistasis	49
klotho	49
antibiotics	49
gene-environment	49
ukm	48
ffpe	48
core-curriculum	48
breakpoint	48
irs1	48
pdk	48
endothelium	48
nrk52e	48
ngal	48
mtorc1	47
spot-urine	47
pooling	47
joint-model	47
ras	46
enos	46
hgf	46
protein-microarray	46
aspirin	46
fdr	46
cystatin	46
dub	46
aldosterone	46
semip	45
biosensor	45
fgf23	45
prevention	45
metal	45
dbdb	45
writing	45
tgfbr	45
sumo	44
variability	44
ancova	44
ecm	44
diuretics	44
interaction	44
mesangial	44
er-stress	44
ccb	44
design	43
klf	43
na	43
cnv	43
bia	43
sle	43
good	42
roc	42
bmi	42
icu	42
stroke	42
agreement	42
asia	42
vsmc	41
catenin	41
fuzzy	41
qtl	41
tlr	40
fibronectin	40
alignment	40
sage	40
hyperfiltration	40
risk	40
gene-targeting	40
wga	40
rca	39
igf	39
urinalysis	39
ap1	39
angiogenesis	39
protein-complex	39
dry-bw	39
omics	38
antisense	38
tea	38
igan	38
rvh	38
myc	38
gsk	37
gsk3	37
adh	37
rsk	37
propensity	37
hematuria	37
bh4	37
glut	37
fabp	37
haplotype	37
emr	37
s100b	36
megalin	36
adenosine	36
animal	36
mtorc2	36
inflammasome	36
snx	36
il1	36
web20	36
cardiorenal	36
proteasome	36
chemogenomics	35
adduct	35
calcification	35
exercise	35
reverse-epidemiology	35
annotation	35
sp1	35
threshold	35
subgroup	35
coffee	35
candidate-gene	35
cre	35
pathology	34
msm	34
effect-size	34
attrition	34
sglt	34
cross-species	34
nephrotoxicity	34
creb	34
sepsis	34
ns	33
sarcopenia	33
rtk	33
pka	33
bmp	33
integrin	33
zeb	33
ecology	33
cage	33
et	32
ai	32
end-point	32
pp2a	32
aa	32
set	32
igf1	32
macrophage	32
text-mining	32
browser	32
zfn	32
steroid	32
fc	32
addgene	32
affy	32
orbitrap	32
transactivation	31
frailty	31
hospitalization	31
risk-difference	31
emsa	31
family	31
heritability	31
abp	31
silac	31
nutrient	31
gllamm	31
blast	31
agt	31
staging	30
cr	30
knockout	30
grn	30
pten	30
transporter	30
reporter	30
mw	30
membrane-protein	30
carcinogen	30
geo	30
notch	30
s100	30
ub-ligase	29
renin	29
nicotinic	29
sgk	29
virus	29
perindopril	29
thesis	29
extraction	29
3	29
human	29
validation	29
time-dependent	28
mutagenesis	28
scaling	28
acetylation	28
pharmacogenetics	28
gsh	28
hplc	28
gee	28